dc.contributor.author | Gutiérrez, A.H. | |
dc.contributor.author | Spero, D.M. | |
dc.contributor.author | Gay, C. | |
dc.contributor.author | Zimic-Peralta, Mirko Juan | |
dc.contributor.author | De Groot, A.S. | |
dc.date.accessioned | 2022-01-18T19:35:50Z | |
dc.date.available | 2022-01-18T19:35:50Z | |
dc.date.issued | 2012 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/11211 | |
dc.description.abstract | The field of "One Health" encourages researchers to collaborate across a wide range of disciplines to improve health at the animal-human- ecosystems interface. One Health recognizes the potential of emerging infectious diseases to impact public health and global food security, and the need for a multidisciplinary approach to counteract the effect of these diseases. Vaccinologists are also beginning to engage in research related to One Health, recognizing that preventing transmission of emerging infectious diseases at the animal-human interface is critically important for protecting the world population from epizootics and pandemics. In this synopsis of recent work in the One Health field, we describe some emerging One Health pathogens, discuss the importance of One Health to food safety and biodefense, propose strategies for improving One Health including the development of new vaccines and new vaccine design approaches, and close with a brief discussion of the opportunities and risks related to One Health vaccine research. | en_US |
dc.language.iso | eng | |
dc.publisher | Taylor and Francis | |
dc.relation.ispartofseries | Human Vaccines and Immunotherapeutics | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | Humans | en_US |
dc.subject | Animals | en_US |
dc.subject | Disease Transmission, Infectious | en_US |
dc.subject | endemic disease | en_US |
dc.subject | unclassified drug | en_US |
dc.subject | morbidity | en_US |
dc.subject | review | en_US |
dc.subject | infection | en_US |
dc.subject | mortality | en_US |
dc.subject | methodology | en_US |
dc.subject | infection control | en_US |
dc.subject | immunology | en_US |
dc.subject | food control | en_US |
dc.subject | Vaccination | en_US |
dc.subject | brucellosis | en_US |
dc.subject | epidemic | en_US |
dc.subject | Food Microbiology | en_US |
dc.subject | Zoonoses | en_US |
dc.subject | vaccine | en_US |
dc.subject | Communicable Diseases | en_US |
dc.subject | leptospirosis | en_US |
dc.subject | virus transmission | en_US |
dc.subject | zoonosis | en_US |
dc.subject | Wart virus vaccine | en_US |
dc.subject | communicable disease | en_US |
dc.subject | drug development | en_US |
dc.subject | Drug Discovery | en_US |
dc.subject | hyaluronic acid | en_US |
dc.subject | food safety | en_US |
dc.subject | adenovirus vector | en_US |
dc.subject | Biodefense | en_US |
dc.subject | biological warfare | en_US |
dc.subject | Burkholderia mallei | en_US |
dc.subject | Burkholderia pseudomallei | en_US |
dc.subject | DNA vaccine | en_US |
dc.subject | drug delivery system | en_US |
dc.subject | drug formulation | en_US |
dc.subject | drug manufacture | en_US |
dc.subject | Emerging pathogens | en_US |
dc.subject | Food Safety | en_US |
dc.subject | foot and mouth disease vaccine | en_US |
dc.subject | Hendra virus infection | en_US |
dc.subject | Henipavirus | en_US |
dc.subject | inactivated virus vaccine | en_US |
dc.subject | influenza A (H5N1) | en_US |
dc.subject | influenza vaccine | en_US |
dc.subject | Influenza virus A H5N1 | en_US |
dc.subject | interdisciplinary research | en_US |
dc.subject | ISCOM | en_US |
dc.subject | liposome | en_US |
dc.subject | macrogol | en_US |
dc.subject | Nipah virus infection | en_US |
dc.subject | One Health | en_US |
dc.subject | peptide vaccine | en_US |
dc.subject | polyanhydride | en_US |
dc.subject | polyglactin | en_US |
dc.subject | polystyrene | en_US |
dc.subject | Rift Valley fever bunyavirus | en_US |
dc.subject | rift valley fever vaccine | en_US |
dc.subject | starch | en_US |
dc.subject | vaccine production | en_US |
dc.subject | Vaccines | en_US |
dc.subject | virosome | en_US |
dc.subject | virus like agent | en_US |
dc.subject | Zoonotic infectious diseases | en_US |
dc.title | New vaccines needed for pathogens infecting animals and humans: One Health | en_US |
dc.type | info:eu-repo/semantics/review | |
dc.identifier.doi | https://doi.org/10.4161/hv.20202 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.01.03 | |
dc.relation.issn | 2164-554X |
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |